Log in
Enquire now
‌

US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Patent 7449458 was granted and assigned to Rigel Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Rigel Pharmaceuticals
Rigel Pharmaceuticals
0
Date Filed
January 19, 2006
0
Date of Patent
November 11, 2008
0
Patent Application Number
11337049
0
Patent Citations Received
‌
US Patent 12091411 IRAK degraders and uses thereof
0
‌
US Patent 11707457 IRAK degraders and uses thereof
0
‌
US Patent 11746120 Stat degraders and uses thereof
‌
US Patent 11779578 IRAK degraders and uses thereof
‌
US Patent 11932635 CRBN ligands and uses thereof
0
‌
US Patent 11932624 MDM2 degraders and uses thereof
0
‌
US Patent 12006329 Protein degraders and uses thereof
0
‌
US Patent 12077555 STAT degraders and uses thereof
0
‌
US Patent 11667611 Compositions and methods for inhibition of the JAK pathway
0
‌
US Patent 11679109 SMARCA degraders and uses thereof
0
•••
Patent Inventor Names
Somasekhar Bhamidipati
0
Rajinder Singh
0
Thomas Sun
0
Valentino J. Stella
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7449458
0
Patent Primary Examiner
‌
Kahsay T. Habte
0

Find more entities like US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.